Artificial intelligence in assessment of hepatocellular carcinoma treatment response.

Journal Article (Journal Article;Review)

Artificial Intelligence (AI) continues to shape the practice of radiology, with imaging of hepatocellular carcinoma (HCC) being of no exception. This article prepared by members of the LI-RADS Treatment Response (TR LI-RADS) work group and associates, presents recent trends in the utility of AI applications for the volumetric evaluation and assessment of HCC treatment response. Various topics including radiomics, prognostic imaging findings, and locoregional therapy (LRT) specific issues will be discussed in the framework of HCC treatment response classification systems with focus on the Liver Reporting and Data System treatment response algorithm (LI-RADS TRA).

Full Text

Duke Authors

Cited Authors

  • Spieler, B; Sabottke, C; Moawad, AW; Gabr, AM; Bashir, MR; Do, RKG; Yaghmai, V; Rozenberg, R; Gerena, M; Yacoub, J; Elsayes, KM

Published Date

  • August 2021

Published In

Volume / Issue

  • 46 / 8

Start / End Page

  • 3660 - 3671

PubMed ID

  • 33786653

Electronic International Standard Serial Number (EISSN)

  • 2366-0058

Digital Object Identifier (DOI)

  • 10.1007/s00261-021-03056-1


  • eng

Conference Location

  • United States